The Interaction of Peripheral Proteins and Membranes Studied with
-Lactalbumin and Phospholipid Bilayers of Various Compositions*
Armelle Varnier Agasøster
,
Øyvind Halskau
,
Edvin Fuglebakk
,
Nils Åge Frøystein ¶,
Arturo Muga ||,
Holm Holmsen
and
Aurora Martínez
**
From the
Department of Biochemistry and Molecular Biology, University of Bergen, Jonas Liesvei 91, N-5009 Bergen, Norway,
¶ Department of Chemistry, University of Bergen, Allégaten 41, N-5007 Bergen, Norway,
|| Department of Biochemistry and Molecular Biology, University of Basque Country, E-48080 Bilbao, Spain
Received for publication, November 11, 2002
, and in revised form, March 25, 2003.
 |
ABSTRACT
|
---|
To characterize the interaction of peripheral proteins and membranes at the molecular level, we studied the reversible association of bovine
-lactalbumin (BLA) with lipid bilayers composed of different molecular forms of phosphatidylserine or equimolar mixtures of these phosphatidylserine forms and egg yolk phosphatidylcholine. At pH 4.5, almost all BLA (>90%) associates to negatively charged small unilamellar vesicles. The conformational changes that binding to these bilayers induced on the protein were characterized by circular dichroism and fluorescence spectroscopy. Because binding of BLA to negatively charged vesicles is reverted by adjusting the pH back to >6.0, we also investigated the conformation of the membrane-bound protein by NMR-monitored H-D exchange of the backbone amide protons. The conformation adopted by BLA bound to these bilayers resembles a molten globule-like state but the negative ellipticity at 222 nm and the apparent
-helix content of the bound protein senses the changes in the physical properties of the membrane. Binding to bilayers in the gel state appears to correlate with an increased amount of
-helical structure and with a lower extent of integration into the membrane, corresponding to the adsorbed protein, while the opposite is found for BLA bound to vesicles in the liquid-crystalline phase, corresponding to the embedded conformation. A common feature for the membrane-bound conformations of BLA is that the amphipathic helix C (residues 86 to 99) is an important determinant for the adsorption and further integration of the protein into the membrane.
 |
INTRODUCTION
|
---|
As a part of their functions, some intracellular proteins can reversibly translocate between the cytosol and membrane surfaces, leading to a change in conformation and a consequent variation in activity (14). Similarly, extracellular proteins such as apolipoproteins can alternatively exist free in plasma or bound to lipoprotein lipids, in which case a new conformation is induced (58). The membrane-bound form of these amphitropic proteins is adsorbed or partially embedded in the lipidic surfaces. Secreted soluble toxins may be inserted through both leaflets of the membrane and in vitro studies have shown a transient membrane-triggered shift of their conformation that is necessary for their insertion in the membrane (9, 10). Among the different factors that modulate the association of proteins with the membrane, the lipid composition seems to be determinant (1, 2, 11, 12). The composition of the lipid bilayer can also act specifically on the conformation of proteins adsorbed or inserted in the membrane (1316).
The soluble, calcium-binding milk protein bovine
-lactalbumin (BLA)1 is a component of the lactose synthase complex. BLA binds to galactosyltransferase, promoting glucose binding and facilitating the synthesis of lactose in the lactating mammary gland (17, 18). BLA can also reversibly associate with lipid membranes under specific conditions. Thus, it has been shown that at pH 4.5, calcium-containing BLA binds to negatively charged liposomes and that the binding is reverted by adjusting the pH back to >6.0 (19). The protein only adsorbs to vesicles made of saturated lipids without disrupting the permeability barrier of the bilayer, whereas it adopts a partial embedded (inserted) state upon binding to vesicles of unsaturated lipids (in the liquid-crystalline phase) able to disrupt the bilayer (20). Our recent NMR studies have lead to a mechanism for the partial insertion of BLA into negatively charged membranes that includes initial protonation of acidic side chains at the membrane interface, which involves helixes A and C, and a subsequent conformational change in the protein that adopts a molten globule-like state to maximize the interaction between hydrophobic residues in these helixes and the lipid bilayer (21). Svensson et al. (22, 23) have characterized an apoptosis-inducing conformer of human
-lactalbumin (human
-lactalbumin made lethal to tumor cells, i.e. HAMLET), that induces the death of tumor cells and immature cells, but does not harm healthy cells. As yet, the mechanism by which a larger protein as the HAMLET conformer of
-lactalbumin induces apoptosis is unknown, but both a partially unfolded conformation and a specific fatty acid as bound cofactor, oleic acid (18:1), are required for this new function of the protein. Conversion of
-lactalbumin to the apoptosis inducing form is achieved with both the protein derived from human milk whey and with recombinant protein expressed in Escherichia coli (23). It has also been recently found that the permeabilizing effect of HAMLET on the mitochondria with subsequent cytochrome c release, which may lead to activation of the caspase cascade and apoptotic death in transformed cells, is dependent on the oleic acid cofactor of HAMLET (24). The specificity of HAMLET for tumor cells leads the attention to the lipids involved in the recognition mechanism. It appears that the membrane composition is different in healthy cells and its corresponding tumor cells (2528). In human breast cancer tissue the amount of phospholipid has been measured to be 3.6-fold higher than in non-tumorous breast tissue (25) and tumor cell membranes contain more anionic phospholipids and a different fatty acid composition (29). Moreover, although the negatively charged phospholipids of the plasma membrane are usually segregated to the inner leaflet (30), the earliest sign of apoptosis is translocation of phosphatidylserine (PS) from the inner to the outer leaflet (31).
To further investigate the conformational changes accompanying the binding of
-lactalbumin to membranes, we have studied the interaction of BLA with liposomes of different composition. The conformation of the membrane-bound states of the protein was investigated by fluorescence spectroscopy, circular dichroism (CD), and 1H NMR. The interaction of BLA with the membrane seems to be mostly modulated by the nature, physical state, and charge of the major lipid components of the membranes, the glycerophospholipids (20). In this study we have studied the interaction of BLA with liposomes made of different molecular forms of PS alone or equimolar mixtures of these lipids and egg yolk phosphatidylcholine (EYPC), thus with bilayers of different fluidity and charge density. Most of the previous studies on the interaction of BLA with model membranes have used liposomes containing negatively charged dioleoylphosphatidylglycerol (DOPG), although this phospholipid generally contributes to less than 1% to the total animal cellular phospholipids, except for the 25% found in lungs (30). Our results with the more relevant PS are compared with previous results obtained with mixtures of EYPC and DOPG.
 |
EXPERIMENTAL PROCEDURES
|
---|
Materials1,2-Distearoyl-sn-glycero-3-(phospho-L-serine) (DSPS), 1-stearoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine) (SOPS), and 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine) (POPS) were purchased from Avanti Polar Lipids (Alabaster, AL). EYPC, 1,2-dioleoylphosphatidylglycerol (DOPG), and bovine
-lactalbumin type III (holo-protein, calcium-saturated) were from Sigma. Deuterium oxide (99.9%) was from ICN Biomedicals Inc. (Costa Mesa, CA). Fura-2 was from Molecular Probes (Leiden, The Netherlands).
Preparation of Unilamellar Lipid VesiclesThe lipids were dissolved in chloroform and mixed in a round-bottom glass flask to the desired proportions. The solvent was evaporated and the lipids freeze-dried overnight. The dried films were then dispersed in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.5, by gently mixing and small unilamellar vesicles (SUV), also referred to as liposomes in the text, were then prepared in a bath sonicator (Branson 1200, Bransonic, CT), operating at a nominal frequency of 20 kHz during 6090 min at 4 °C. The temperature was maintained by continuous exchange of the chilled water. A highly homogeneous vesicle preparation with a diameter of 40 nm was obtained, as seen by electron microscopy and quasi-elastic light scattering using a Malvern Zetasizer (Malvern, United Kingdom). Electron microscopy revealed that SUV were unilamellar. Large unilamellar vesicles (LUV) (
1 µm diameter) were prepared by extrusion as described (32).
Binding of
-Lactalbumin to Liposomes by UltracentrifugationProtein solutions (7 µM) and liposomes were mixed in 1 ml of 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.56.0, at the indicated lipid:protein ratios. Samples were allowed to equilibrate for 30 min at room temperature and were then centrifuged at 105,000 x g for 30 min at 4 °C. The protein concentration in the supernatant was determined spectrophotometrically, using the extinction coefficients of 28,500 M–1 cm1 at 280 nm, pH 7.0 (33). To account for the sedimentation of the free protein, samples containing the same protein concentration in the absence of liposomes were treated and centrifuged under the same experimental conditions.
Determination of Free Calcium ContentCalcium concentration was measured using the Ca2+ indicator fura-2 (34) using a LS-50B PerkinElmer luminescence spectrometer, according to the product information manual from the manufacturer of fura-2 (Molecular Probes) and references therein. Calcium was measured in samples of BLA (0.1 mM) prepared in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.5 and 6.0, both in the presence and the absence of liposomes composed of EYPC: DOPG (1:1) and EYPC:SOPS (1:1) (7 mM phospholipid). Calcium was also measured after adjusting the pH of the samples to 6.0 in membrane-free protein fractions and in both membrane- and protein-free fractions prepared by ultrafiltration in Centricon 3 microconcentrators (Amicon) using 1 µM fura-2.
Differential Scanning CalorimetryMeasurements were performed on a MicroCal VP-DSC differential scanning calorimeter (MicroCal, Inc.) with cell volumes of 0.5 ml at a scan rate of 60 °C/h. All buffer solutions were degassed under vacuum prior to use. Calorimetric cells were kept under an excess pressure of 207 kPa to prevent degassing during the scan. SUV (5 mM in phospholipid) prepared in a 20 mM citric acid/Na2HPO4, 0.1 M NaCl buffer, at the indicated pH, were used, and thermograms of buffer served as reference. When indicated, BLA was present at a concentration of 5070 µM. Determination of the transition temperature (TC) and the half-widths of the transitions (TC
) was performed by curve fitting with the Origin TM software (MicroCal, Inc.).
Fluorescence SpectroscopyFluorescence measurements were performed at 25 °C with a PerkinElmer luminescence spectrometer LS-50B with temperature regulation using quartz cuvettes with a light path of 5 mm. Samples contained 1 µM BLA in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.5 to 6.0, in the presence or absence of liposomes (300 µM in lipid). The fluorescence emission spectra of the protein were recorded in the 310500 nm range with excitation at 295 nm using 3- and 5-nm band widths in the excitation and emission pathways, respectively. Protein-free blanks with and without liposomes of identical concentration and composition were subtracted. When indicated, the pH of the sample was adjusted from pH 4.5 to 6.0 by the addition of NaOH and incubation up to 30 min at 25 °C.
Circular Dichroism (CD)CD measurements were performed with a Jasco J-810 spectropolarimeter equipped with a PTC-348WI Peltier element for temperature control using quartz cells with path lengths of 1 mm. Samples contained 12.7 µM BLA in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.5 to 6.0, in the presence and absence of liposomes (882 µM in lipid) at the indicated temperature. Four consecutive wavelength scans between 195 and 260 nm were recorded for each CD spectrum and buffer blanks were subtracted. Protein thermal denaturation was monitored by following the changes in ellipticity at 222 nm, with a scan rate of 1 °C/min in the 1095 °C temperature range. Mean residue ellipticity (
) was calculated from the formula
=
/(10Cnl), where
is the ellipticity (millidegrees), l is the path of the cuvette (cm), C is the protein concentration (mol/liter), and n is the number of amino acid residues in the protein (123 for BLA). Analysis of the data and determination of midpoint denaturation temperatures (Tm) of the protein were performed using the Standard Analysis program provided with the instrument. The amount of secondary structure elements was estimated with the CDNN program that applies a neural network procedure (35).
Hydrogen-Deuterium Exchange and NMR SpectroscopySamples of BLA (1 mM final concentration, 550 µl) were prepared in 99.9% D2O-containing 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pD 4.5, in the absence and presence of liposomes of different phospholipid composition to give a final lipid:protein molar ratio of 70. Total binding of the protein was controlled by ultracentrifugation and by the increase in fluorescence emission intensity (see above). Protons of BLA were then allowed to exchange with deuterium by incubation at 4 °C for 1 h, together with a reference sample that was prepared in the same buffer but in the absence of SUV. The pD was then adjusted to pD 6.0 by adding NaOH to release the protein from the membrane and NMR spectra were acquired.
All NMR experiments were performed on a Bruker DRX 600 MHz spectrometer equipped with pulsed field gradient accessories. Band-selective homonuclear decoupled TOCSY (BASHD-TOCSY) experiments (36) were performed at a probe temperature of 308 K, to diminish adverse effects from high viscosity in the samples with liposomes. The spectra were acquired with a spectral width of 2.1 ppm in the evolution dimension (F1) and 14.985 ppm in the acquisition dimension (F2). The strength of the Gaussian cascade Q3 pulse was calibrated by setting its integral equal to a conventional hard
-pulse. The frequency offset of the soft pulse was adjusted to be [4.55-
water]·600.13 Hz, where
water is the water resonance frequency in ppm and 4.55 is the center of the excitation profile in the F1 dimension. The pulse program contained water suppression using pulse sculpting (37) and the "W5" modification of the 3-9-19 "Watergate" sequence (38). The number of scans was 96 and the time domain in F2 and F1 were 2048 and 32 complex points, respectively. Mixing time for the spin-lock field was set to 40 ms, the strength of the DIPSI-2 spin lock field was
6 kHz, and the recycling delay was set to 1.0 s. This set-up yielded an experimental time of 1 h and 8 min. Spectra processing was performed using the Xwinnmr (Bruker) software and volume of the cross-peaks in each of the BASHDTOCSY spectra was measured using Sparky 3.95 (39) by the sum over ellipsoid method. The resulting integrals of the
H-NH cross-peaks were divided by the volume of the non-exchanging cross-peak assigned to W26 H6H7.
 |
RESULTS
|
---|
Fluorescence and Differential Scanning Calorimetry MeasurementsThe pH-controlled reversible interaction of BLA with negatively charged liposomes of EYPC:DOPG (1:1) has been characterized by several spectroscopic techniques, including fluorescence spectroscopy (19). BLA free in solution shows an intrinsic fluorescence emission spectrum with
max at about 330331 nm both at pH 4.5 and 6.0 (Fig. 1) and on binding to liposomes of EYPC:DOPG at pH 4.5, the fluorescence intensity increases and the
max red shifts to 339340 nm (19). These changes have been interpreted as being the result of the transition of at least one of its four Trp residues to a more polar environment and the disappearance of tertiary interactions that quench the fluorescence in the native state (19). No spectral changes occur when liposomes (either LUVs or SUVs) of EYPC:DOPG are added to BLA at pH 6.0 and additional methods, such as ultracentrifugation, have corroborated that no binding takes place at this pH (19, 21). Incubation of the protein with SUVs at protein:lipid molar ratios ranging from 1:70 to 1:300 at pH 4.5 and 37 °C, and consequent ultracentrifugation of the samples, reveals that almost all BLA (>90%) associates to SUV made of EYPC:DOPG, EYPC:SOPS, EYPC: POPS, and EYPC:DSPS. Full binding of BLA was also measured after incubation with the same lipid bilayers at 25 °C, except for those composed of EYPC:DSPS, for which no binding was observed at this temperature.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1. Effect of liposomes of EYPC, EYPC:SOPS, and EYPC: DSPS on the tryptophan emission fluorescence of BLA. Measurements were performed with 1 µM BLA at 37 °C in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, either pH 4.5 or 6.0, in the absence or presence of liposomes made of EYPC alone (), after 20 min of the addition of liposomes of EYPC:SOPS (···), or EYPC:DSPS (-··-) at pH 4.5 and after 15 s of increasing the pH to 6.0 (- -). The liposomes (SUV) of the indicated composition were 300 µM in lipid.
|
|
Liposomes (either LUVs or SUVs) of EYPC alone do not affect the emission fluorescence of BLA at either pH (Fig. 1). A red-shift and an increase in fluorescence intensity are also observed on binding of BLA to liposomes of EYPC:SOPS and EYPC:POPS, whereas a blue shift was observed for the interaction of the protein with liposomes of EYPC:DSPS at 37 °C (Fig. 1 and Table I).
To check the thermotropic properties of these samples they were characterized by differential scanning calorimetry, and in Table II we have summarized the gel to liquid crystalline phase transition temperatures (TC) of the bilayers. It should be mentioned that we focused on the characterization of SUVs because the advantageous use of these liposomes over LUV in the spectroscopic experiments, where higher lipid concentrations are required, has been discussed elsewhere (21). The values of TC obtained by differential scanning calorimetry for SUV containing pure PS species are consistent with data for the gel to liquid crystalline phase transition for LUV and MLV of the same phospholipids found in the LIPIDAT data base (40). The TC values for the mixtures of EYPC and different molecular species of PS in the absence of BLA are lower than for the pure PS species (Table II). The analysis of the pH dependence of TC, sensitive to the degree of ionization, the surface charge density, and the fluidity (41, 42), indicates that the PS species used in this study are negatively charged in the pH 4.56 range.
View this table:
[in this window]
[in a new window]
|
TABLE II Temperature for the gel to liquid crystalline phase transition (TC) and half-width (TC ) of the transition obtained by differential scanning calorimetry for the SUV preparations studied
|
|
When the pH was increased from 4.5 to 6.0, the fluorescence spectrum of BLA in the presence of liposomes essentially reverted to that for free BLA (Ref. 21, Fig. 1, and data not shown), in accordance with the release of the protein from the bilayer. Measurement of the calcium content in solutions of BLA bound to liposomes of EYPC:DOPG and EYPC:SOPS at a lipid:protein molar ratio of 300:1 at pH 4.5 using the fluorescence properties of fura-2 (34) showed that no calcium ion is released to the medium from the protein on binding to the bilayer, indicating that membrane-bound BLA most probably remains as holoenzyme. Moreover, BLA released from the membrane by the pH shift to pH 6.0 appears to be recovered largely (80%) as holoenzyme.
The Association of BLA with Liposomes of Different Compositions Studied by CDThe far-ultraviolet spectrum of free BLA shows two minima at 208 and 222 nm, characteristic of proteins with large content of
-helical structure (Ref. 19 and Fig. 2A). The content of
-helix and
-extended structures in BLA estimated from the CD spectrum was 27 and 10%, respectively, in agreement with the content estimated from the crystal structure (43). In the presence of liposomes of EYPC:DOPG, EYPC:SOPS, EYPC:POPS, and EYPC:DSPS at pH 4.5 and 10 °C, an increase was observed in the ellipticity of BLA (Fig. 2A), corresponding to larger apparent
-helix content than in free BLA (Table III). When the CD spectra were acquired at 37 °C, the negative ellipticity at 222 nm of BLA and the apparent
-helix content was lower for BLA bound to the equimolar mixtures of EYPC and PS (Table III). This effect was better studied by following the temperature-induced changes on the ellipticity at 222 nm (the benchmark for
-helix). Representative profiles are shown in Fig. 2B. When bound to liposomes of EYPC:DOPG, no significant changes were found for the scans of BLA with respect to that of free protein, whereas remarkable features were observed in the temperature scans of BLA bound to liposomes of EYPC:SOPS (Fig. 2B), EYPC:POPS, or EYPC: DSPS (data not shown). A sudden and significant (about 40%) reduction of
-helix content was observed for BLA bound to liposomes of EYPC:SOPS in the 2550 °C temperature range. Complementary experiments intended to follow the kinetics of the cooperative conformational changes associated with the binding of BLA to liposomes of EYPC:SOPS at 25 °C showed that the ellipticity at 222 nm first increased for 10 min up to 10% and then deceased to 60% of its original value in the free protein.
View this table:
[in this window]
[in a new window]
|
TABLE III Apparent -helical content of BLA in solution and bound to SUV of different phospholipidic composition at pH 4.5
|
|
The Association of BLA with Liposomes of Different Composition Studied by NMRAmide proton (NH) exchange data can be used to probe molecular interactions and conformational changes by NMR. The effect of binding of a ligand to the protein on the time course of signal decay resulting from hydrogen exchange can be assessed by comparison with the exchange rates of the protein alone (44, 45). Thus, the regions involved in the binding to the ligands (with slower exchange rate because of protection by the ligand) and/or the conformational changes, including the extent of protein unfolding necessary to become competent in membrane association, may be identified. Using this method we have recently identified regions of BLA involved in binding to liposomes of EYPC:DOPG (21). We intended to extend this method to study the binding of BLA to liposomes containing different molecular species of PS, and compare the results with those obtained for BLA bound to liposomes of EYPC:DOPG (and consequently released), for which the H-D exchange of about 20% of the NH protons can be followed up to 5 days and be compared with that in control samples of BLA free in solution (21). However, NH signals disappeared very quickly when the protein was allowed to exchange in D2O while bound to the liposomes made of EYPC: SOPS, EYPC:POPS, or EYPC:DSPS at pH 4.5 at a temperature of either 4 or 25 °C. Almost no NH signal was detected for exchange time >1 h when the spectra were taken after release by pH shift to 6.0. Thus, proper decay curves could not be calculated because the time between pH shift and acquisition (necessary for tuning, matching, shimming, and pulse calibration) was about 40 min. Therefore, we decided to compare the remaining backbone amide protons after H-D exchange for 1 h. To shorten the acquisition time for NMR spectra while still retaining high signal-to-noise ratio and a reasonable resolution, the NMR method chosen was BASHD-TOCSY (36). Experimental parameters were adjusted for the rapidly acquired BASHD-TOCSY spectra so that the majority (about 80%) of the
H-NH signals were included in the spectral window for free BLA in solution (10% D2O, pH 4.5). About 80% of the
H-NH cross-peaks have been identified and assigned in this spectrum (21) based on previous work by Forge et al. (46) and Alexandrescu et al. (47). When incubation and exchange in D2O was performed at 4 °C, a temperature which is over the TC for bilayers of EYPC:DOPG (40), but lower than the TC for the transition of the PS containing SUV (Table II), several
H-NH cross-peaks can be detected after 1 h of exchange in control samples of free BLA (Fig. 3A) and for BLA bound to liposomes of EYPC:DOPG (Fig. 3B). On the other hand, most protons in BLA bound to liposomes of EYPC:SOPS were found to be fast-exchanging protons, and were undetected or show less than 0.1 of their normalized intensity at the same conditions (kex > 1 x 102 min1) (Fig. 3C). Moreover, for BLA bound to liposomes of EYPC:POPS or EYPC:DSPS, no signal was detected in the released sample after 1 h exchange in D2O. To assess if the disappearance of the signals in the spectrum of the released samples was because of complete proton exchange or to rapid proton relaxation we acquired BASHD-TOCSY spectra in released BLA after 48 h incubation at 4 °C with liposomes of EYPC:POPS at pH 4.5 in 10% D2O. At these conditions, all the signals were clearly detected (Fig. 4), confirming that the lack of signal observed when the incubation was performed with 100% deuterium for 1 h was because of complete proton exchange, and not to rapid proton relaxation.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3. BASHD-TOCSY spectra of BLA showing the H-NH region. Spectra were taken in samples of BLA (1 mM) in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.5, 100% D2O after 1 h incubation at 4 °C with subsequent increase of the pH to 6.0 to release the protein in the samples with liposomes. Incubation was in the absence (A) and presence of SUV (70 mM lipid) of EYPC:DOPG (B) or EYPC:SOPS (C). Spectra were taken at a probe temperature of 308 K.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4. BASHD-TOCSY spectrum of BLA with liposomes of EYPC:SOPS showing the H-NH region. BLA (1 mM) was prepared in 20 mM citric acid/Na2HPO4, 0.1 M NaCl, pH 4.5, 10% D2O with SUV of EYPC:SOPS, and the spectrum was taken 48 h after incubation at 4 °C and subsequent increase of the pH to 6.0 to release the protein from the liposomes. Spectra were taken at a probe temperature of 308 K.
|
|
Although no complete NH exchange rates could be calculated for the BLA forms when bound to liposomes of EYPC:SOPS, the analysis of the NMR spectra taken after 1 h of exchange give valuable insights on the conformation of the protein bound to bilayers made of different anionic phospholipids and in different physical states, i.e. the gel state (EYPC:SOPS) and the liquid-crystalline state (EYPC:DOPG). The visible peaks were integrated and their normalized intensity is summarized in Table IV, whereas their intensities in the bound forms related to that in control samples of free protein are shown in Fig. 5. The low intensity ratio of the liposome-bound samples is in agreement with an overall exchange behavior of the membrane-bound protein that adopts a molten globule-like conformation (19, 21, 48). Some few amide protons appeared to be more protected in the membrane-bound BLA (Fig. 5). From the residues found to be more protected in BLA bound to EYPC: DOPG liposomes than in the free native BLA after 1 h of exchange in 100% D2O, Arg10, Leu12, Lys94, Lys98, Val99, and Trp104 agree with those found by analysis of complete exchange-rate data taken up to 5 days of exchange (21). Because these residues also show a higher protection than in the acidic molten globule-like form (46), these results indicate that they are involved in membrane binding. When BLA is associated with liposomes of EYPC:SOPS, only residues Lys98 and Val99 from helix C are more protected from exchange than in the native free protein (Table IV and Fig. 5). The relative peak volume corresponding to Val99 was even larger with EYPC: SOPS than with EYPC:DOPG vesicles, suggesting a closer association of the end of the helix C with the membrane. The protected residues in EYPC:DOPG- and EYPC:SOPS-bound BLA with respect to the free enzyme were mapped into the crystal structure of BLA (43) (Fig. 6, A and B).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 5. Relative protection to H-D exchange of the backbone amide protons of membrane bound BLA. Relative intensities of the visible H-NH cross-peaks for BLA that had been incubated in D2O buffer at pH 4.5 and 4 °C, in the presence of SUV made of EYPC:DOPG (black bars) or EYPC:SOPS (gray bars), as compared with the corresponding intensity in a control sample of protein in solution. Data from Table IV.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6. Structure of BLA (Protein Data Bank accession code 1HFZ
[PDB]
) and location of the most protected residues in the protein bound to liposomes. The structure is according to data from Table IV for SUV made of EYPC:DOPG (A) or EYPC:SOPS (B). C, representation of the -helix C in BLA (Thr86Val99) showing its amphipathic character, with a hydrophobic and a charged side.
|
|
 |
DISCUSSION
|
---|
The interaction of amphiphilic molecules and amphitropic proteins with membranes has been proposed to be modulated by the surface charge and the physical state of the latter (4, 8, 49, 50). In the present study we have investigated the binding of BLA to PS-containing bilayers with acyl chains of varying unsaturation and length. Combined with analysis of the binding at different temperatures, this allows for a large variability in the chemical composition and physical state of the membranes.
As indicated by CD spectroscopy, the conformation of BLA bound to liposomes of EYPC:DOPG at 37 °C is similar to that obtained at 10 °C. EYPC and DOPG show a high degree of miscibility and are in a liquid crystalline state at temperatures above 0 °C. On the other hand, during temperature scans of the protein bound to EYPC:PS mixtures, the protein experiences a change in the physical state of the bilayers at temperatures around TC (Table II). Whereas the spectra taken at 4 °C correspond to gel phase-bound protein, at 37 °C both EYPC:SOPS and EYPC:POPS are entirely in the liquid crystalline state and EYPC:DSPS is at the pretransition. In agreement with earlier results by Bañuelos and Muga (20) working with derivatives of BLA, the sudden decrease in ellipticity that the protein undergoes at temperatures right above TC might be related to the existence of two bound forms of the protein: (i) adsorbed species characterized by a high content of
-helix, and (ii) embedded species, located further into the bilayer. The protein both adsorbs and partially inserts into membranes in the liquid crystalline state, but it cannot penetrate into the hydrocarbon core of the bilayer in the gel phase (20). Our NMR results further contribute to the characterization of these conformers. Whereas the data are acquired at higher temperatures to decrease viscosity of the samples, the H-D exchange is performed at 4 °C and the results provide information on the bound conformation at this temperature, i.e. the embedded form in the case of EYPC:DOPG bilayers or the adsorbed conformation in the case of BLA bound to EYPC:SOPS. The rapid and generalized exchange indicates that both forms correspond to a molten globule-like conformer. However, a comparison of the adsorbed and embedded conformations reveals that the former is less protected from the solvent, only two residues being more protected from exchange than in the embedded form (Lys98 and Val99). This would be in agreement with a more superficial and exposed localization of the adsorbed form with respect to the embedded form. A further NMR investigation of the change in protein conformation associated with the insertion of the protein into the membrane expected during the gel to liquid crystalline transition is hindered by the large H-D exchange rate constants at temperatures >4 °C (51). Common to the association of BLA with liposomes made of EYPC:DOPG and EYPC: SOPS, helix C seems to be involved in the interaction. This helix has a typical amphipathic character (Fig. 6C), and its involvement in binding may possibly be related to the increased apparent helicoidal content of membrane-bound proteins (1, 52). Put together, our results are in agreement with a higher structuration or stabilization of the interacting helix (helices) in the membrane-adsorbed BLA and a larger unfolding of the membrane-embedded protein.
The fluorescence data corresponding to BLA bound to EYPC: DOPG, EYPC:SOPS, and EYPC:POPS are consistent with the exposure of (a) Trp residue(s) to the solvent (or the polar membrane interface) as well as the disappearance of tertiary interactions that quench the fluorescence in the native state (19), in agreement with a molten globule-like form. As seen by NMR, Trp104 seems to be an appropriate candidate for being located at the polar solvent-membrane interface (Table IV and Ref. 21). However, BLA bound to EYPC:DSPS bilayers at 37 °C, which shows the characteristic increase in fluorescence of the molten globule-like membrane-bound conformations, displays a blue-shifted fluorescence emission spectrum, probably indicating a different chemical environment, more apolar, for the Trp residue in this conformer bound to an ordered membrane.
Although BLA is a Ca2+ containing protein, the increase in TC that accompanies the interaction of the protein with bilayers composed only of EYPC:SOPS and EYPC:POPS (Table II) cannot be merely related to thermotropic effects of the cation binding to the membrane, because at a similar Ca2+:lipid molar ratio as the protein:lipid ratio utilized in this study, no effect on TC is observed (41).2 Nevertheless, it is interesting to note that in our proposed scheme, in which helix C (residues 8698) is involved in membrane binding, the Ca2+ ion (coordinated by Lys79, Asp84, Asp82, Asp87, and Asp88 in the holoprotein (43)), would be brought close to the surface of the membrane where the negatively charged head groups of the phospholipids can compete with the protein for the cation. Moreover, the affinity of the molten globule for Ca2+ is lower than that of the native form (53), which would facilitate calcium release from the membrane-bound form of BLA, and its possible binding to the membrane. Accordingly, a minor (20%) but significant proportion of BLA is recovered from the bilayer as apoprotein in solution after the pH shift to 6.0 (Ref. 21 and this work), which seems to be relevant for understanding the finding by Håkansson et al. (54) and Svensson et al. (22, 23) that fatty acid (18:1) containing folding variant forms of human
-lactalbumin are calcium-elevating and apoptosis-inducing agents, with cytotoxic activity for transformed, embryonic, and lymphoid cells. Peptides with antibacterial and apoptotic activity on tumor cells (Ref. 55 and references therein) are characterized for their high content of basic amino acids, a motif that is also found in helix C of BLA. It seems clear that the apoptotic character of HAMLET is connected with its special folding state that must be able to both transverse the membranes of the vulnerable cells and induce the DNA fragmentation noted by Håkansson et al. (56). A possible relevant observation is that HAMLET is isolated from the casein fraction when purified from milk at pH 4.6, 40 °C (22). This contrasts with the fact that native
-lactalbumin is purified from the whey fraction (57). Caseins have been described as "naturally occurring molten globules," and attempts have been made to explain their structure and properties by invoking the concept of tensegrity (58). Tensegrity applied to protein structure implies that relatively rigid secondary structure is linked by flexible loops, and that these secondary structural motifs are held together by a balancing of tension and repulsion. Such structures are large and open and highly hydrated. Our studies on the bilayer interaction of BLA, indicate the molten globule as the necessary intermediate for efficient membrane association. Translocation of the protein across the bilayers, however, is expected to require large scale disruption of the phospholipids molecular arrangement. Thus, the necessary conditions for translocation may be offered by a combination of the large HAMLET complex with its oleic cofactor bound, which could stabilize the tensegral structure, and a specific phospholipid composition of the membrane. Further studies on the effect of protein concentration and membrane composition on the conformation adopted by membrane-bound BLA and its degree of insertion into the membrane will contribute to understand the selectivity of some folding variants of human
-lactalbumin to induce apoptosis in tumor cells (22, 23).
 |
FOOTNOTES
|
---|
* This work was supported by the Research Council of Norway, European Community BIOMED-2 Grant BMH4-CT-972609, and University of the Basque Country Grant UPV 13505/2001. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 
Both authors contributed equally to this work. 
** To whom correspondence should be addressed. Tel.: 47-55-58-64-27; Fax: 47-55-58-63-60; E-mail: aurora.martinez{at}ibmb.uib.no.
1 The abbreviations used are: BLA, bovine
-lactalbumin; DOPG, 1,2-dioleoyl-sn-glycero-3-(phospho-1-glycerol); DSPS, 1,2-distearoyl-sn-glycero-3-(phospho-L-serine); EYPC, egg yolk phosphatidylcholine; LUV, large unilamellar vesicles; SOPS, 1-stearoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine); POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine); PS, phosphatidylserine; SUV, small unilamellar vesicles. 
2 A. V. Agasøster, E. Fuglebakk, H. Holmsen, and A. Martínez, unpublished results. 
 |
ACKNOWLEDGMENTS
|
---|
We thank Dr. Matthías Thórólfsson for help with the calorimetric experiments.
 |
REFERENCES
|
---|
- Johnson, J. E., and Cornell, R. B. (1999) Mol. Membr. Biol. 16, 217235[CrossRef][Medline]
[Order article via Infotrieve]
- Medkova, M., and Cho, W. (1998) Biochemistry 37, 48924900[CrossRef][Medline]
[Order article via Infotrieve]
- Yang, W., Boggs, K. P., and Jackowski, S. (1995) J. Biol. Chem. 270, 2395123957[Abstract/Free Full Text]
- Cornell, R. B., and Northwood, I. C. (2000) Trends Biochem. Sci. 25, 441447[CrossRef][Medline]
[Order article via Infotrieve]
- Fisher, C. A., and Ryan, R. O. (1999) J. Lipid Res. 40, 9399[Abstract/Free Full Text]
- Sahoo, D., Narayanaswami, V., Kay, C. M., and Ryan, R. O. (1998) J. Biol. Chem. 273, 14031408[Abstract/Free Full Text]
- Soulages, J. L., and Arrese, E. L. (2000) J. Biol. Chem. 275, 1750117509[Abstract/Free Full Text]
- Wang, S. X., Sun, Y. T., and Sui, S. F. (2000) Biochem. J. 348, 103106[CrossRef][Medline]
[Order article via Infotrieve]
- Lakey, J. H., Parker, M. W., Gonzalez-Mañas, J. M., Duche, D., Vriend, G., Baty, D., and Pattus, F. (1994) Eur. J. Biochem. 220, 155163[Abstract]
- Caaveiro, J. M., Echabe, I., Gutierrez-Aguirre, I., Nieva, J. L., Arrondo, J. L., and Gonzalez-Manas, J. M. (2001) Biophys. J. 80, 13431353[Abstract/Free Full Text]
- Dahim, M., and Brockman, H. (1998) Biochemistry 37, 83698377[CrossRef][Medline]
[Order article via Infotrieve]
- Killian, J. A., and von Heijne, G. (2000) Trends Biochem. Sci. 25, 429434[CrossRef][Medline]
[Order article via Infotrieve]
- Kirsch, T., Nah, H. D., Demuth, D. R., Harrison, G., Golub, E. E., Adams, S. L., and Pacifici, M. (1997) Biochemistry 36, 33593367[CrossRef][Medline]
[Order article via Infotrieve]
- Braschi, S., Neville, T. A., Vohl, M. C., and Sparks, D. L. (1999) J. Lipid Res. 40, 522532[Abstract/Free Full Text]
- Baenziger, J. E., Morris, M. L., Darsaut, T. E., and Ryan, S. E. (2000) J. Biol. Chem. 275, 777784[Abstract/Free Full Text]
- Gadd, M. E., and Biltonen, R. L. (2000) Biochemistry 39, 96239631[CrossRef][Medline]
[Order article via Infotrieve]
- Schanbacher, F. L., and Ebner, K. E. (1971) Biochim. Biophys. Acta 229, 226232[Medline]
[Order article via Infotrieve]
- Permyakov, E. A., and Berliner, L. J. (2000) FEBS Lett. 473, 269274[CrossRef][Medline]
[Order article via Infotrieve]
- Bañuelos, S., and Muga, A. (1995) J. Biol. Chem. 270, 2991029915[Abstract/Free Full Text]
- Bañuelos, S., and Muga, A. (1996) FEBS Lett. 386, 2125[CrossRef][Medline]
[Order article via Infotrieve]
- Halskau, O., Froystein, N. A., Muga, A., and Martinez, A. (2002) J. Mol. Biol. 321, 99110[CrossRef][Medline]
[Order article via Infotrieve]
- Svensson, M., Sabharwal, H., Håkansson, A., Mossberg, A. K., Lipniunas, P., Leffler, H., Svanborg, C., and Linse, S. (1999) J. Biol. Chem. 274, 63886396[Abstract/Free Full Text]
- Svensson, M., Håkansson, A., Mossberg, A. K., Linse, S., and Svanborg, C. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 42214226[Abstract/Free Full Text]
- Kohler, C., Gogvadze, V., Håkansson, A., Svanborg, C., Orrenius, S., and Zhivotovsky, B. (2001) Eur. J. Biochem. 268, 186191[Abstract/Free Full Text]
- Hietanen, E., Punnonen, K., Punnonen, R., and Auvinen, O. (1986) Carcinogenesis 7, 19651969[Abstract]
- Chajes, V., Lanson, M., Fetissof, F., Lhuillery, C., and Bougnoux, P. (1995) Int. J. Cancer 63, 169175[Medline]
[Order article via Infotrieve]
- Chajes, V., Hulten, K., Van Kappel, A. L., Winkvist, A., Kaaks, R., Hallmans, G., Lenner, P., and Riboli, E. (1999) Int. J. Cancer. 83, 585590[CrossRef][Medline]
[Order article via Infotrieve]
- Monteggia, E., Colombo, I., Guerra, A., and Berra, B. (2000) Cancer Detect. Prev. 24, 207211[Medline]
[Order article via Infotrieve]
- Van Blitterswijk, W. J., De Veer, G., Krol, J. H., and Emmelot, P. (1982) Biochim. Biophys. Acta 688, 495504[Medline]
[Order article via Infotrieve]
- Cullis, P. R., and Hope, M. J. (1991) in Biochemistry of Lipids, Lipoproteins and Membranes (Vance, D. E., and Vance, J., eds) Vol. 20, pp. 141, Elsevier Science Publishers B. V., Amsterdam
- Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. (1995) J. Immunol. Methods 184, 3951[CrossRef][Medline]
[Order article via Infotrieve]
- Nerdal, W., Gundersen, S. A., Thorsen, V., Hoiland, H., and Holmsen, H. (2000) Biochim. Biophys. Acta 1464, 165175[Medline]
[Order article via Infotrieve]
- Ewbank, J. J., and Creighton, T. E. (1993) Biochemistry 32, 36943707[Medline]
[Order article via Infotrieve]
- Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 34403450[Abstract]
- Bohm, G., Muhr, R., and Jaenicke, R. (1992) Protein Eng. 5, 191195[Abstract]
- Krishnamurthy, V. V. (1997) Magn. Reson. Chem. 35, 912[CrossRef]
- Hwang, T.-L., and Shaka, A. J. (1995) J. Magn. Reson. Ser. A 112, 275279[CrossRef]
- Liu, M., Mao, X., Ye, C., Huang, H., Nicholson, J. K., and Lindon, J. C. (1998) J. Magn. Res. 132, 125129[CrossRef]
- Goddard, T. D., and Kneller, D. G. (1999) SPARKY 3, University of California, San Francisco, CA (www.cgl.ucsf.edu/home/sparky/)
- Caffrey, M., and Hogan, J. (1992) Chem. Phys. Lipids 61, 1109[CrossRef][Medline]
[Order article via Infotrieve]
- van Dijck, P. W., de Kruijff, B., Verkleij, A. J., van Deenen, L. L., and de Gier, J. (1978) Biochim. Biophys. Acta 512, 8496[Medline]
[Order article via Infotrieve]
- Phillips, M. C., Ladbrooke, B. D., and Chapman, D. (1970) Biochim. Biophys. Acta 196, 3544[Medline]
[Order article via Infotrieve]
- Pike, A. C., Brew, K., and Acharya, K. R. (1996) Structure 4, 691703[Medline]
[Order article via Infotrieve]
- Bai, Y., Milne, J. S., Mayne, L., and Englander, S. W. (1993) Proteins 17, 7586[Medline]
[Order article via Infotrieve]
- Schulman, B. A., Redfield, C., Peng, Z. Y., Dobson, C. M., and Kim, P. S. (1995) J. Mol. Biol. 253, 651657[CrossRef][Medline]
[Order article via Infotrieve]
- Forge, V., Wijesinha, R. T., Balbach, J., Brew, K., Robinson, C. V., Redfield, C., and Dobson, C. M. (1999) J. Mol. Biol. 288, 673688[CrossRef][Medline]
[Order article via Infotrieve]
- Alexandrescu, A. T., Broadhurst, R. W., Wormald, C., Chyan, C. L., Baum, J., and Dobson, C. M. (1992) Eur. J. Biochem. 210, 699709[Abstract]
- Bañuelos, S., and Muga, A. (1996) Biochemistry 35, 38923898[CrossRef][Medline]
[Order article via Infotrieve]
- Kim, J., Blackshear, P. J., Johnson, J. D., and McLaughlin, S. (1994) Biophys. J. 67, 227237[Abstract]
- Agasøster, A. V., Tungodden, L. M., Cejka, D., Bakstad, E., Sydnes, L. K., and Holmsen, H. (2001) Biochem. Pharmacol. 61, 817825[CrossRef][Medline]
[Order article via Infotrieve]
- Englander, S. W., and Mayne, L. (1992) Annu. Rev. Biophys. Biomol. Struct. 21, 243265[CrossRef][Medline]
[Order article via Infotrieve]
- White, S. H., and Wimley, W. C. (1999) Annu. Rev. Biophys. Biomol. Struct. 28, 319365[CrossRef][Medline]
[Order article via Infotrieve]
- Kuwajima, K. (1989) Proteins Struct. Funct. Genet. 6, 87103[Medline]
[Order article via Infotrieve]
- Håkansson, A., Zhivotovsky, B., Orrenius, S., Sabharwal, H., and Svanborg, C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 80648068[Abstract]
- Wang, W., Smith, D. K., Moulding, K., and Chen, H. M. (1998) J. Biol. Chem. 273, 2743827448[Abstract/Free Full Text]
- Håkansson, A., Andreasson, J., Zhivotovsky, B., Karpman, D., Orrenius, S., and Svanborg, C. (1999) Exp. Cell Res. 246, 451460[CrossRef][Medline]
[Order article via Infotrieve]
- Imafidon, G. I., Farkye, N. Y., and Spanier, A. M. (1997) Crit. Rev. Food Sci. Nutr. 37, 663689[Medline]
[Order article via Infotrieve]
- Farrell, H. M., Jr., Qi, P. X., Brown, E. M., Cooke, P. H., Tunick, M. H., Wickham, E. D., and Unruh, J. J. (2002) J. Dairy Sci. 85, 459471[Abstract/Free Full Text]